arrow
Back
S

Sophie Marolleau

Aix Marseille University and Inria and Inserm and CNRS

2H-index
8Paper Count
15Citation Count
Published Papers 5
Publication Date
Model-Driven Optimization of Subcutaneous Polymer Prodrugs Achieves Cancer Remission in Mice
err2026-03-17
err0
errOAAI
errAnne Rodallec; Randy Lee; Jingming Cao; Sophie Marolleau; Julien Nicolas; Sébastien Benzekry
errShare
errSave
PK/PD analysis of pembrolizumab, nivolumab and atezolizumab in NSCLC patients: The PIONeeR trial
err2024-09-01
err0
PREAI
errCiccolini, J.; Hamimed, M.; Marolleau, S.; Perez, C.; Benzekry, S.; Le Ray, M.; Boyer, A.; Audigier-Valette, C.; Martinez, S.; Pegliasco, H.; Ray, P.; Falchero, L.; Serre, A.; Cloarec, N.; Lebas, L.; Hominal, S.; Mazieres, J.; Perol, M.; Greillier, L.; Barlesi, F.
errShare
errSave
Killing a fly with a sledgehammer: standard flat-dosing administration of Atezolizumab leads to marked overexposure in real-world lung cancer patients
err2024-03-22
err0
PREAI
errMarolleau, Sophie; Mogenet, Alice; Hamimed, Mourad; Boeri, Clara; Greillier, Laurent; Ciccolini, Joseph
errShare
errSave
Killing a fly with a sledgehammer: Atezolizumab exposure in real-world lung cancer patients
err2023-11-27
err2
errOAAI
errMarolleau, Sophie; Mogenet, Alice; Boeri, Clara; Hamimed, Mourad; Ciccolini, Joseph; Greillier, Laurent
errShare
errSave
Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?
err2022-01-18
err4
errOAAI
errBaklouti, S.; Marolleau, S.; Chavanet, P.; Bonnet, E.; Concordet, D.; Gandia, P.
errShare
errSave